Correspondence to: T Hensel Rat C6 glioma. a glial brain tumour cell line induced bv N-nitrosomethxlurea. shows rapid and diffuse infiltration of brain tissue in Xivo. Venr similar to human glioblastomas (Benda et al. 1968). In several in v-itro models wxe showed that C6 glioma cells rapidly invade optic nerve explants and spread on CNS tissue and purified CNS mvelin. C6 cell spreading and migration on CNS mxelin can be blocked by metalloprotease blockers such as o-phenanthroline. Awhereas blockers for senine. aspartx l and cy steine proteases had no effect (Paganetti et al. 1988 : Amberger et al. 1994 . These results suggest the involvement of a metalloproteolv-tic activitx in the process of migration of C6 gllioma cells on myelin and mvelinated CNS tissue. A nea-l-designed tetrapeptide. cbz-phe-ala-phe-tyramide. inhibits C6 glioma cell spreading and is degraded with a slox-time course (AAmberger et al. 1994). A degradation assax usinc the iodinated tetrapeptide led to the characterization of the inx ol ed proteolvtic actix ity (AAmberger et al. 1994). A similar metalloproteolvtic actix-itx was also found in a series of high-grade human glioma lines and primary tumours .
metalloproteases (Ennis and Matrisian. 1994) . plasminogen actixator (Mignatti and Rifkin. 1996) and proteases of the cathepsin fami1x (Rochefort. 1994 ) has been shown. especiallx for the formation of metastases: the breakdow-n of cell-cell contacts and the extracellular matrix enables the tumour cells to mig-rate through peripheral tissues and to enter and leax e the blood stream.
Interestingly. the metastases from peripheral tumours. even highly invasive ones. form onlv circumscribed tumours in the brain and do not show anv infiltratinc behaxiour within the CNS tissue. In contrast. hichlx invasix-e CNS tumours rarelv metastasize to peripheral organs. These obserxations suggest a different mechanism for tumour cell migration within the CNS.
High-grade astrocv-tomas. such as glioblastoma multiforme. are characterized bv the diffuse infiltration of the surroundinc CNS tissue (Kleihues et al. 1993) . Malignant tumour cells migrate along blood xessels without intrax-asation (Bemstein et al. 1990: Giese and Westphal. 1996) . but the preferred route for glioma dissemination is aloncg white matter fibre tracts (Russel and Rubinstein. 1989 ). CNS white matter. hoxwever. contains inhibitonr proteins for neurite outgrow-th. axon regeneration and for spreading and migration of different cell types. including astrocN-tes and fibroblasts (Caroni and Schw-ab. 1988 : Schw ab and Carom'. 1988 : Spillmann et al. 1997 ).
Rat C6 glioma. a glial brain tumour cell line induced bv N-nitrosomethxlurea. shows rapid and diffuse infiltration of brain tissue in Xivo. Venr similar to human glioblastomas (Benda et al. 1968) . In several in v-itro models wxe showed that C6 glioma cells rapidly invade optic nerve explants and spread on CNS tissue and purified CNS mvelin. C6 cell spreading and migration on CNS mxelin can be blocked by metalloprotease blockers such as o-phenanthroline. Awhereas blockers for senine. aspartx l and cy steine proteases had no effect (Paganetti et al. 1988 : Amberger et al. 1994 . These results suggest the involvement of a metalloproteolv-tic activitx in the process of migration of C6 gllioma cells on myelin and mvelinated CNS tissue. A nea-l-designed tetrapeptide. cbz-phe-ala-phe-tyramide. inhibits C6 glioma cell spreading and is degraded with a slox-time course (AAmberger et al. 1994) . A degradation assax usinc the iodinated tetrapeptide led to the characterization of the inx ol ed proteolvtic actix ity (AAmberger et al. 1994) . A similar metalloproteolvtic actix-itx was also found in a series of high-grade human glioma lines and primary tumours .
In the present studyxw e report the partial purification of a metalloendoprotease (C6-MPA). expressed in the plasma membrane of C6 gllioma cells. Fractions highlx enriched in metalloproteolvtic activitx neutralize the inhibitor-substrate properties of CNS mvelin and inactixate the neurite grou-th inhibitor-protein bNI-220 as shoxwn in in xitro cell spreadinc assays. bNI-220 is the bomine homologue of the neurite growth inhibitorx protein NI-35/250 previously found in rat CNS myelin . Antibodies w ere raised in chicken against C6-MPAcontaining fractions. The effect of these antibodies was tested in tissue culture experiments. as wxell as the peptide degradation assay: in the presence of these antibodies C6 cell spreading, on CNS m-elin >-as efficientiv blocked. and cell migration of glioblastomas >-as significantlv reduced. (Spillmann et al. 1997 ).
Substrates w-ere applied to culture dishes (1 cm') )Greiner.
NUrtingen. Germany). incubated oxer night at 4 C and washed tx-ice wxith Ca--. Msi--free Hanks' balanced salt solution. The coated >-ells were used immediately for the spreading assay by adding 10 000 cells cm-'. After Sianificance w-as exaluated using the unpaired t-test (P < 0.01).
Inhibition experiments w ere performed w-ith nerve explants prexiously injected with 10 tl of IgY solution (5 gia purified antibodies ml-). Antibodies w-ere present during the w hole experiment (5 jig ml' in the inner and 2.5 jgc ml-' in the outer chambers).
Purification of C6-MPA C6 plasma membranes w ere prepared as described by rAmberger et al (1994) w-ith some modifications. C6 cells wxere growxn in roller bottles )Costar. 2550 ml). scraped off at confluency and frozen at -70-C. After thawxing the cell suspension >-as homogenized and a crude plasma membrane fraction w as obtained by sucrose density centrifugation . The enrichement of C6 plasma membranes w-as determined by measurinn the 5'-nucleotidase actixity. a marker enzvrme for plasma membranes (Ames. 1966) . To measure the metalloproteolytic activity of the purified material the degradation of cbz-phe-ala-phe-tN r-amide >-as analvsed accordinc to the protocol of Amberger et al (1994) . To remoxve associated membrane proteins the plasma membrane fractions w-ere diluted in MES buffer containing 1 Im marnesium chloride. shaken for 1 h at 4'C and centrifuged (20 000 g. 1 h). To solubilize integral membrane proteins the pellet was resuspended in I ml of 20 mm MES buffer. overnight, and applied to a Superdex 75 column (Pharmacia), previously equilibrated with 20 M MES buffer with 100 iM sodium chloride and 0.5% CHAPS, pH 6.0. The separation was run at a flow rate of 0.5 ml min-' and fractions of 0.5 ml were collected and tested for enzyme activity. In the last purification step, the pooled fractions from size exclusion chromatography were separated again on Mono-Q FPLC under the same conditions.
Treatmen of bN1-220 with C6MPA
bNI-220 (bovine) was coated on four-well culture dishes and incubated for 30 min with C6-MPA-enriched fractions (10 jig ml-') at 37°C in the presence or absence of EDTA (I mm). Dishes were washed twice with Ca2+-, Mg2+-free Hanks' balanced salt solution and used immediately for the spreading assay by adding 10 000 3T3 fibroblasts cm-2. Cells were incubated for 1 h at 37°C, fixed and evaluated as described above.
Raising of antibodies
Two brown hens, 22 weeks old, were used for immunization according to the protocol of Gassmann et al (1990) . Mono-Q fraction (1 ml) (last purification step) enriched in C6-MPA (0.3 mg protein ml-') was emulsified with 1 ml of complete Freund's adjuvant (Gibco Laboratories, New York, USA). The suspension was injected into the pectoral muscle at four different sites. The first boost (using complete Freund's adjuvant) was carried out after IgY was purified from individual eggs with the EGGstract IgY purification system from Promega (Madison, WI, USA). The yolk was carefully separated from the egg white, and yolk lipids were precipitated IgY was precipitated from the filtered supenatant while stirring at room temperature and stored in PBS supplemented with 0.01% sodium azide in concentrations of 1 mg ml-l at 4°C. The same procedure was performed with preimmune yolk to obtain control antibodies.
Gel ek s and immunobloting Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed on 5% and 7.5% polyacrylamide gels according to Laemmli (1970) . Gels were stained with silver nitrate for protein detection. For immunoblotting fractions of anion and size exclusion columns were separated on 7.5% SDS-PAGE and transferred to a PVDF membrane. The membrane was blocked with 3% gelafine hydrolysate in PBS and incubated with IgY antibodies (5 jg ml-') in Tris-buffered saline (TBS, 10 mm Tris-HCI, pH 7.5, 0.1 M sodium chloride). The secondary antibody (Promega), coupled to alkaline phosphatase, was used in dilution 1:5000. The bound alkaline phosphatase was localized using BCIP (5-bromo4-chloro-3-indolylphosphate p-toluidine) and NBT (nitroblue tetrazolium chloride) as substrates.
RESULTS
Partial purfication of a membrane-bound metaloprotease from rat C6 glioma cells
Crude cell homogenate of C6 glioma cells was fractionated by sucrose density centrifugation, resulting in a plasma membrane, a nuclear and a mitochondrial fraction. The enrichment of plasma membranes was assessed by measuring the 5' nucleotidase The peptide degrading activity described in all these steps has always been tested for its sensitivity to specific metalloprotease blockers. The C6-MPA is blocked by 10 jM o-phenanthroline. a chelating agent that inhibits metalloproteases. and by 10 gM phoshoramidone. whereas 300 jM thiorphan had no effect. This result is in agreement with the blocking effects seen on the C6 enzyme and on C6 cell spreading on a myelin protein substrate (Paganetti et al, 1988; Amberger et al. 1994 ). The enriched metalloproteolytic activity obtained by this procedure was used for the experiments described below.
C6-MPA inactfvates neurite growth inhibitors present in CNS myelin
CNS myelin and the neurite growth inhibitory protein bNI-220 were purified from bovine spinal cords and were used as substrates for cell spreading of 3T3 fibroblasts and C6 glioma cells. 3T3 fibroblasts attached and spread on control substrate (Figure 2A ). whereas cell spreading was completely inhibited on the inhibitory substrates ( Figure 2B ). C6 glioma cells attached and spread equally well on control dishes ( Figure 2C ) and on culture dishes coated with bNI-220 ( Figure 2D ). Preincubation of bNI-220-coated culture dishes with C6-MPA-enriched fractions for 30 min at 37°C changed the substrate properties: 3T3 fibroblasts attached rapidly and spreading was advanced after I h ( Figure 2E ). Pretreatment of bNI-220 with C6-MPA in the presence of EDTA. a chelating agent that inhibits metalloproteases, retained the inhibitory effect of bNI-220 and 3T3 fibroblast spreading was inhibited ( Figure 2F ). Quantitative analysis of the inactivation of bNI-220 by C6-MPA is shown in Figure 3 . Coating of 0.5 jg bNl-220 cm-2 inhibited cell spreading of about 80% 3T3 fibroblasts British Journal of Cancer (1998) 78(12), [1564] [1565] [1566] [1567] [1568] [1569] [1570] [1571] [1572] T T Trne (m-) during a 90-min incubation. The same result was obtained by coating 15 gg of bovine CNS myelin extract (74% inhibited 3T3 fibroblasts). Pretreatment with C6-MPA (1 jg cm-2) neutralized the inhibitory substrate effect of bNI-220 for 3T3 fibroblasts as seen by a massive reduction in inhibited 3T3 cells (10% inhibited cells: significance. P < 0.001). This inactivation of bNI-220 by C6-MPA was strongly impaired by the presence of EDTA (1 mM). EDTA alone showed no effect on the inhibitory activity of bNI-220. Pretreatment of bNI-220 with an inactive fraction (flow through of second Mono Q) did not reduce the inhibitory substrate properties: 78% of the fibroblasts were inhibited after 90 min. Using control substrate in the presence of C6-MPA and EDTA. no influence in the spreading ability of 3T3 fibroblasts compared with control substrate alone was observed (24% cells inhibited). These results show that the inhibitory protein bNI-220. present in CNS myelin. is inactivated by C6-MPA. The sensitivity of the C6-MPA to EDTA confirms the metalloproteolytic nature of this enzyme.
Polyclonal antibodies against C6-MPA
In an attempt to obtain further tools to purify and study the C6-MPA we immunized two hens with a fraction enriched in C6-MPA (Mono Q. last punrfication step. Table 1 ). The antibodies (IgY) were purified from the egg yolk. Control antibodies were obtained from preimmune yolk of the same hens.
To assay for the presence of antibodies directed against C6-MPA. the effect of IgYs was first tested in the peptide degradation and C6 cell spreading assays. As shown in 
Antibody effects on C6 cell migration
The migration ability of C6 glioma cells in the presence or absence of antibodies was tested using slides that were coated either with CNS myelin extract or with poly-L-lysineIBSA as control substrate. Cells were plated into narrow bore cylinders that were Figure 5 Effect of IgYs on C6 glioma cell spreading. A total of 10 000 C6 cels were plated on CNS mnyelin-coated dishes (B, C) and control dies (A) in the presence of 3 pg ml-' immune IgY (A, B) or preimmune IgY (C). The dishes were incubated for 1 h at 3TC. Bar = 50 gm explants in a special chamber culture system as described Thoenen. 1985: Paganetti et al. 1988) . After 14 days in vitro. the optic nerves were serially sectioned and the cells in the different parts of the explants were counted under the fluorescence microscope ( Table 2 ).
The cell numbers found in the head of the explants. close to where C6 cells were originally placed. were the same between explants without antibodies and explants in the presence of control antibodies. whereas they were reduced in the presence of immune IgYs. A clear reduction was also seen in the other parts of the explants in the presence of immune IgYs. The total number of infiltrating cells in the explants cultivated in the presence of immune IgYs was about half of that in explants without antibodies (Table 2 ). A molecular weight range of 66 to 96 kD has been estimated for C6-MPA in earlier studies using HPLC (Amberger et al. 1994 ). The present results show that antibodies raised against a protein fraction . One important component of the brain white matter is myelin. containing specific membrane proteins that inhibit axon regeneration. neurite outgrowth and cell spreading of astrocytes and fibroblasts (Caromn et al. 1988 : Rubin et al. 1995 lTe fact that the main route of malignant brain tumour infiltration is along white matter fibre tracts suggests that gliomas use a specific mechanism to overcome the effect of these myelinassociated inhibitory proteins. O-Phenanthroline. a chelator that inhibits metalloproteases. and the derived tetrapeptide cbz-FAFYamide inhibit spreading and migration of C6 cells as well as human glioblastoma cells on CNS myelin in vitro (Paganetti et al. 1988; Amberger et al. 1994 Amberger et al. . 1997 . This shows that a mietalloproteolytic activity, blocked by o-phenanthroline or the tetrapeptide. is necessary in a mechanism involved specifically in glioma cell spreading on CNS myelin. In the present study we have shown that a C6 glioma plasma membrane fraction enriched in metalloproteolytic activity inactivates the inhibitory substrate properties of CNS myelin as well as highly purified bNI-220 (bovine homologue of NI-250) for cell spreading. This inactivation was blocked in the presence of EDTA. confirming the action of a metalloprotease.
Immunoblots
Antibodies raised in chicken against plasma membrane fractions enriched in metalloproteolytic activity reduced the degrading activity of C6-MPA. suggesting that these polyclonal antibodies contain antibodies against this metalloprotease (although an indirect masking effect cannot be excluded at present). That a certain amount of the tetrapetide was still degraded might be explained by the possibility that the antibodies do not bind directly to the active centre of the protease but to a region close by. Cell spreading and migration on myelin and invasion of C6 glioma cells into optic nerve explants were significantly reduced in the presence of the antibodies. indicating the involvement of proteins recognized by the antibodies, e.g. the C6-MPA. SDS-PAGE and immunoblots point to candidate bands for C6-MPA in the molecular weight range of 75-SO kDa. This is in line with earlier estimates of the molecular weight range of this membrane-bound metalloendoprotease between 66 and 96 kDa (Amberger et al. 1994 ).
Tumour cells produce several classes of proteases. such as matnix metalloproteases (MMPs). serine proteases. cysteine proteases and aspartyl proteases. that have been involved in migration and invasion of different tumour types (Ennis and Matrisian. 1994; Romanic and Madri. 1994) . Recently. a new class of membrane-bound matrix metalloproteases (MT-MMPs) has been identified (Sato et al. 1994 ). The expression of MT-MMP-I is correlated with gelatinase A activation, and MT-MMP-1 mRNA was found to be significantly elevated in malignant astrocytomas (Yamamoto et al. 1996) .
Our results suggest that migration of glioblastoma cells along white matter fibre tracts of the CNS is not simply the result of structural factors, but involves the inactivation of specific inhibitory substrate properties of CNS myelin by a crucial involvement of a membrane-bound metalloprotease. The subsequent molecular interactions of the migrating glioblastomas with myelin. white matter astrocytes or axons remain unknown. The impairment of cell migration by inactivation of the metalloprotease shown here in vitro points to interesting future applications of metalloprotease blockers for the prevention of glioblastoma spread in vivo.
